General form of registration statement for all companies including face-amount certificate companies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)

v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (USD $)
 9 Months Ended 12 Months Ended 110 Months Ended 119 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Dec. 31, 2004
Dec. 31, 2003
Dec. 31, 2011
Sep. 30, 2012
Net loss $ (6,639,926) $ (5,469,502) $ (7,435,422) $ (4,560,263) $ (6,219,873) $ (6,090,715) $ (5,090,325) $ (963,440) $ (481,837) $ (342,761) $ (295,790) $ (31,480,426) $ (38,120,352)
Adjustments to reconcile net loss to cash used in operating activities                         7,486,674
Changes in working capital                         609,801
Cash used in operating activities (4,891,171) (4,434,607) (5,970,090) (3,382,447)               (25,132,706) (30,023,877)
CASH FLOWS FROM INVESTING ACTIVITIES:                          
Cash acquired in a business combination 0 905,649 905,649 0               905,649 905,649
Purchases of fixed assets, net of $7,000 proceeds from sale of fixed assets (37,142) (112,195) (118,411) (1,652)               (5,486,592) (5,516,734)
Change in restricted cash 0 500,000 500,000 0               (55,000) (55,000)
Payment for intangible assets 0 0 0 0               (19,671) (19,671)
Cash provided by (used in) investing activities (37,142) 1,293,454 1,287,238 (1,652)               (4,648,614) (4,685,756)
CASH FLOWS FROM FINANCING ACTIVITIES:                          
Proceeds from issuance of common stock and warrants, net of issuance costs, repurchase of common stock, and cash paid in lieu of fractional shares in a business combination 0 0 0 2,720,985               2,720,985 37,114,220
Change in deferred issuance costs 0 (130,800) 28,500 99,461               28,500 28,500
Proceeds from issuance of long-term obligations and convertible notes 0 0 0 450,000               1,677,945 4,398,930
Payments on long-term obligations 0 (675,743) (675,743) (190,789)               (1,227,944) (1,234,253)
Cash provided by (used in) financing activities 5,020,117 4,058,169 9,515,073 3,077,713               35,287,280 40,307,397
INCREASE IN CASH AND EQUIVALENTS 91,804 917,016 4,832,221 (306,386)               5,505,960 5,597,764
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 5,505,960 673,739 673,739 980,125               0 0
CASH AND EQUIVALENTS AT END OF PERIOD 5,597,764 1,590,755 5,505,960 673,739 980,125             5,505,960 5,597,764
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION                          
Interest paid 0 13,716 13,716 54,454               208,689 208,689
Fair value of derivative warrants reclassified to additional paid-in capital upon cashless exercise 43,855 48,339 48,339 0               48,339 92,194
Issuance of common stock upon the conversion of notes payable and accrued interest 0 3,184,707 3,184,707 0               3,184,707 3,184,707
Fair value of assets acquired in exchange for securities in a business combination 0 78,408 78,408 0               78,408 78,408
Fair value of liabilities assumed in exchange for securities in a business combination 0 (439,616) (439,616) 0               (439,616) (439,616)
Excess of purchase price over net assets acquired in a business combination                         $ 1,675,462